StockData
Alaunos Therapeutics, Inc. logo

Alaunos Therapeutics, Inc. (TCRT) stock

TCRTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 4/30
$1.59−0.13 (-7.56%)

Close on Nov 19, 2026Market cap $4.04MP/E –Yield –

Alaunos Therapeutics price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Alaunos Therapeutics's price to sales ratio was 456.4× on Jul 31, 2025, against 46.9× a year earlier. Over the last 4 years it ranged from 6.6× to 494.7×, with a median of 235.4×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2025Jul 31, 2025456.4×+449.8
2023Oct 31, 20236.6×−275.6
2022May 31, 2022282.1×+99.2
2019Jan 31, 2019183.0×+30.2
2018Dec 31, 2018152.8×−298.0
2014Apr 30, 2014450.7×−3.3
2013Dec 31, 2013454.0×+40.0
2012Dec 31, 2012414.0×–

More Alaunos Therapeutics figures

See a number that looks wrong?